Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
CRO
NJ biopharmas make pledge to give time off for clinical trials
Amicus, Bristol Myers Squibb, Genmab, PsychoGenics, PTC Therapeutics and Sanofi have committed to the "Time Off for Clinical Trials" initiative.
Darren Incorvaia
Nov 20, 2024 10:00am
J&J, Protagonist's oral psoriasis prospect scores in phase 3s
Nov 19, 2024 11:44am
BMS' CAR-T cracks down on lupus, achieving sustained responses
Nov 14, 2024 10:00am
Biogen boosts C-suite with BMS vet—Chutes & Ladders
Nov 1, 2024 8:30am
BMS academic partner wins $615k for green chemistry team-up
Oct 28, 2024 11:42am
Terray assembles $120M series B to advance AI-powered molecules
Oct 17, 2024 10:37am
